Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 34

Sort by

Sort Order Select

Journal Articles

Pre-Transplant Minimal Residual Disease Evaluation Performed By Molecular WT1-Based or Multicolor Flow Cytometry Assessment Overcomes the Prognostic Value of Cytogenetic and Molecular Risk Factors at Diagnosis in Advanced Acute Myeloid Leukemia Patients

Fabio Guolo, MD, Paola Minetto, MD, Marino Clavio, MD, Nicoletta Colombo, PhD, Annalisa Kunkl, MD, Enrico Carminati, Carmen Di Grazia, MD, Anna Maria Raiola, MD, Filippo Ballerini, MD, Maurizio Miglino, PhD, Emanuele Angelucci, Roberto M Lemoli, MD, Marco Gobbi, MD

Blood (2017) 130 (Supplement 1): 3316.

https://doi.org/10.1182/blood.V130.Suppl_1.3316.3316

Published: 2017

Journal Articles

First Report of the Gimema LAL1811 Phase II Prospective Study of the Combination of Steroids with Ponatinib As Frontline Therapy of Elderly or Unfit Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Blood (2017) 130 (Supplement 1): 99.

https://doi.org/10.1182/blood.V130.Suppl_1.99.99

Published: 2017

Journal Articles

Comparison of the Efficacy and Feasibility of R-CODOX-M/IVAC-R Versus Conventional R-CHOP As First Line Regimen for High Risk Diffuse Large B-Cell Lymphoma

Giulia Bartalucci, MD, Elisa Coviello, MD, Fabio Guolo, MD, Paola Minetto, MD, Massimiliano Gambella, Giulia Rivoli, MD, Daniela Guardo, MD, Filippo Ballerini, MD, Maurizio Miglino, PhD, Alberto Fabbri, MD, Roberto M Lemoli, MD, Monica Bocchia, Marco Gobbi, MD

Blood (2017) 130 (Supplement 1): 2851.

https://doi.org/10.1182/blood.V130.Suppl_1.2851.2851

Published: 2017

Journal Articles

Higher Versus Standard Doses of Recombinant Erythropoietin for the Treatment of Anemia in Patients with Myelodysplastic Syndromes: Results of a Retrospective Survey from the Italian Registry of Myelodisplastic Syndromes (FISM)

Blood (2016) 128 (22): 4342.

https://doi.org/10.1182/blood.V128.22.4342.4342

Published: 2016

Journal Articles

Predictors for Response to Ruxolitinib in Real-Life: An Observational Independent Study on 408 Patients with Myelofibrosis

Blood (2016) 128 (22): 1128.

https://doi.org/10.1182/blood.V128.22.1128.1128

Published: 2016

Journal Articles

CD38 Deregulation As Strategy to Make Multiple Myeloma Cells More Sensitive to NAD+ Depleting Agents

Michele Cea, MD, Antonia Cagnetta, MD, Debora Soncini, PhD, Paola Minetto, MD, Micaela Bergamaschi, MD, Giulia Rivoli, MD, Letizia Canepa, MD, Marco Gobbi, MD, Roberto M Lemoli, MD

Blood (2016) 128 (22): 5671.

https://doi.org/10.1182/blood.V128.22.5671.5671

Published: 2016

Journal Articles

SIRT6 Inhibition As a Novel Approach for Treating Acute Myeloid Leukemia

Michele Cea, MD, Antonia Cagnetta, MD, Debora Soncini, PhD, Paola Minetto, MD, Davide Lovera, MD, Fabio Guolo, MD, Nicoletta Colombo, PhD, Filippo Ballerini, MD, Marino Clavio, MD, Maurizio Miglino, PhD, Marco Gobbi, MD, Roberto M Lemoli, MD

Blood (2016) 128 (22): 5222.

https://doi.org/10.1182/blood.V128.22.5222.5222

Published: 2016

Journal Articles

PGE 2 -Independent Expression of Indoleamine 2,3-Dioxygenase-2 (IDO2) Supports the Tolerogenic Function of Monocyte-Derived Dendritic Cells,

Sara Trabanelli, Antonio Curti, MD, Darina Ocadlikova, Cecilia Evangelisti, Valentina Salvestrini, Marilena Ciciarello, Michela Aluigi, PhD, Lara Rossi, Richard Metz, Lisa Laury-Kleintop, George Prendergast, Roberto M. Lemoli, MD

Blood (2011) 118 (21): 3231.

https://doi.org/10.1182/blood.V118.21.3231.3231

Published: 2011

Journal Articles

Integrin Alpha E (CD103) Beta 7 Expression Marks A Subset of Human Bone Marrow-Derived CD207 + Dendritic Cells Which Induce T Regulatory Cells Via Indoleamine 2,3-Dioxygenase,

Antonio Curti, MD, Darina Ocadlikova, Sara Trabanelli, Cecilia Evangelisti, Marilena Ciciarello, Michele Baccarani, MD, Roberto M. Lemoli, MD

Blood (2011) 118 (21): 3233.

https://doi.org/10.1182/blood.V118.21.3233.3233

Published: 2011

Journal Articles

CD4 + T-Cell Functions Are Modulated by the Extracellular ATP Concentration

Sara Trabanelli, Darina Ocadlikova, Sara Gulinelli, Marco Idzko, M.D., Antonio Curti, MD, Francesco Di Virgilio, Davide Ferrari, Roberto M. Lemoli, MD

Blood (2011) 118 (21): 2190.

https://doi.org/10.1182/blood.V118.21.2190.2190

Published: 2011

Journal Articles

Plerixafor for Autologous Peripheral Blood Stem Cell Mobilization in Patients Previously Treated with Fludarabine or Lenalidomide

Florent Malard, Nicolaus Kröger, Ian H Gabriel, Dr, Kai Hübel, MD, Jane F. Apperley, MBChB, FRCP, FRCPath, Grzegorz Basak, MD, PhD, Kenneth W Douglas, MD, Catarina Geraldes, MD, Ozren Jaksic, MD, PhD, Zdenek Koristek, MD, PhD, Francesco Lanza, MD, Roberto M. Lemoli, MD, Gabor Mikala, MD, PhD, Dominik Selleslag, MD, Nina Worel, MD, Rafael F. Duarte, MD, PhD, Mohamad Mohty

Blood (2011) 118 (21): 1932.

https://doi.org/10.1182/blood.V118.21.1932.1932

Published: 2011

Journal Articles

Stem Cell Mobilization in Poor Mobilizers Using Plerixafor and G-CSF with or without Chemotherapy: A European Perspective

Maximilian M Fresen, MD, Rafael F. Duarte, MD, PhD, Jane F Apperley, MBChB, MD, FRCP, FRCPath, Grzegorz Basak, MD, PhD, Kenneth W Douglas, MD, Ian H Gabriel, MD, Catarina Geraldes, MD, Ozren Jaksic, MD, PhD, Zdenek Koristek, MD, PhD, Nicolaus Kröger, Francesco Lanza, MD, Roberto M. Lemoli, MD, Gabor Mikala, MD, PhD, Dominik Selleslag, MD, Nina Worel, MD, Florian Lange, Mohamad Mohty, Kai Hübel, MD

Blood (2011) 118 (21): 2993.

https://doi.org/10.1182/blood.V118.21.2993.2993

Published: 2011

Journal Articles

Decreased Expression of Indoleamine 2,3-Dioxygenase 1 in Dendritic Cells From Patients with Immune Thrombocytopenia Induces Impaired Regulatory T-Cell Development

Lucia Catani, BS, Daria Sollazzo, BS, Sara Trabanelli, Cecilia Evangelisti, Antonio Curti, MD, Nicola Polverelli, MD, Francesca Palandri, Michele Baccarani, MD, Nicola Vianelli, MD, Roberto M. Lemoli, MD

Blood (2011) 118 (21): 696.

https://doi.org/10.1182/blood.V118.21.696.696

Published: 2011

Journal Articles

Gpr171, a Putative P2Y-Like Receptor, Counteracts Monocyte Lineage Specification When Over-Expressed In Murine Hematopoietic Progenitors.

Lara Rossi, Roberto M. Lemoli, MD, Margaret A. Goodell, PhD

Blood (2010) 116 (21): 3758.

https://doi.org/10.1182/blood.V116.21.3758.3758

Published: 2010

Journal Articles

Purinergic Stimulation of Human Bone Marrow-Derived Mesenchymal Stem Cells Modulate Their Function and Differentiation Potential.

Marilena Ciciarello, Valentina Salvestrini, Davide Ferrari, Sara Gulinelli, Roberta Zini, Rossella Manfredini, Luisa Caione, Wanda Piacibello, MD, Giovanna Lucchetti, Lara Rossi, Sergio Ferrari, Francesco Di Virgilio, Roberto M. Lemoli, MD

Blood (2010) 116 (21): 3848.

https://doi.org/10.1182/blood.V116.21.3848.3848

Published: 2010

Journal Articles

The CD47 Pathway Is Deregulated In Human Immune Thrombocytopenia (ITP).

Lucia Catani, BS, Daria Sollazzo, BS, Francesca Ricci, BS, Francesca Palandri, Nicola Polverelli, MD, Michele Baccarani, Nicola Vianelli, MD, Roberto M. Lemoli, MD

Blood (2010) 116 (21): 3776.

https://doi.org/10.1182/blood.V116.21.3776.3776

Published: 2010

Journal Articles

CD133 + Pluripotent Stem Cells for the Treatment of Chronic Liver Failure.

Lucia Catani, BS, Stefania Lorenzini, MD, Rosaria Giordano, MD, Paolo Caraceni, MD, Maria Rosa Motta, BS, Valeria Giudice, MD, Tiziana Montemurro, MD, Ferdinando Giannone, MD, Daria Sollazzo, Elisa Dan, BS, Benedetta Nicolini, BS, Francesca Chelli, Michele Baccarani, MD, Mauro Bernardi, MD, Francesco Losinno, MD, Pietro Andreone, MD, Roberto M. Lemoli, MD

Blood (2010) 116 (21): 1185.

https://doi.org/10.1182/blood.V116.21.1185.1185

Published: 2010

Journal Articles

Human Monocyte-Derived Dendritic Cells Are Tolerogenic through Both IDO1 and IDO2

Sara Trabanelli, PhD, Antonio Curti, PhD, Darina Očadlíková, PhD, Cecilia Evangelisti, PhD, Valentina Salvestrini, PhD, Richard Metz, PhD, Lisa Laury-Kleintop, PhD, George Prendergast, Roberto M. Lemoli, MD

Blood (2010) 116 (21): 4298.

https://doi.org/10.1182/blood.V116.21.4298.4298

Published: 2010

Journal Articles

Decreased Expression of Indoleamine 2,3-Dioxygenase 1 (IDO 1) in Dendritic Cells From Patients with Immune Thrombocytopenia (ITP) Correlates with Impaired Regulatory T Cells Development

Lucia Catani, BS, Daria Sollazzo, BS, Antonio Curti, MD, Sara Trabanelli, PhD, Cecilia Evangelisti, PhD, Francesca Palandri, MD, Nicola Polverelli, MD, Michele Baccarani, MD, Nicola Vianelli, MD, Roberto M. Lemoli, MD

Blood (2010) 116 (21): 2770.

https://doi.org/10.1182/blood.V116.21.2770.2770

Published: 2010

Journal Articles

Purinergic Signaling Differentially Modulates Normal and Leukemic Hematopoiesis.

Valentina Salvestrini, BS, Sara Gulinelli, BS, Roberta Zini, BS, Luisa Caione, BS, Giorgia Migliardi, BS, Wanda Piacibello, MD, Davide Ferrari, PhD, Francesco Di Virgilio, MD, Sergio Ferrari, MD, Rossella Manfredini, PhD, Roberto M Lemoli, MD

Blood (2009) 114 (22): 1436.

https://doi.org/10.1182/blood.V114.22.1436.1436

Published: 2009

NARROW

Pre-Transplant Minimal Residual Disease Evaluation Performed By Molecular WT1-Based or Multicolor Flow Cytometry Assessment Overcomes the Prognostic Value of Cytogenetic and Molecular Risk Factors at Diagnosis in Advanced Acute Myeloid Leukemia Patients

First Report of the Gimema LAL1811 Phase II Prospective Study of the Combination of Steroids with Ponatinib As Frontline Therapy of Elderly or Unfit Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Comparison of the Efficacy and Feasibility of R-CODOX-M/IVAC-R Versus Conventional R-CHOP As First Line Regimen for High Risk Diffuse Large B-Cell Lymphoma

Higher Versus Standard Doses of Recombinant Erythropoietin for the Treatment of Anemia in Patients with Myelodysplastic Syndromes: Results of a Retrospective Survey from the Italian Registry of Myelodisplastic Syndromes (FISM)

Predictors for Response to Ruxolitinib in Real-Life: An Observational Independent Study on 408 Patients with Myelofibrosis

CD38 Deregulation As Strategy to Make Multiple Myeloma Cells More Sensitive to NAD+ Depleting Agents

SIRT6 Inhibition As a Novel Approach for Treating Acute Myeloid Leukemia

PGE 2 -Independent Expression of Indoleamine 2,3-Dioxygenase-2 (IDO2) Supports the Tolerogenic Function of Monocyte-Derived Dendritic Cells,

Integrin Alpha E (CD103) Beta 7 Expression Marks A Subset of Human Bone Marrow-Derived CD207 + Dendritic Cells Which Induce T Regulatory Cells Via Indoleamine 2,3-Dioxygenase,

CD4 + T-Cell Functions Are Modulated by the Extracellular ATP Concentration

Plerixafor for Autologous Peripheral Blood Stem Cell Mobilization in Patients Previously Treated with Fludarabine or Lenalidomide

Stem Cell Mobilization in Poor Mobilizers Using Plerixafor and G-CSF with or without Chemotherapy: A European Perspective

Decreased Expression of Indoleamine 2,3-Dioxygenase 1 in Dendritic Cells From Patients with Immune Thrombocytopenia Induces Impaired Regulatory T-Cell Development

Gpr171, a Putative P2Y-Like Receptor, Counteracts Monocyte Lineage Specification When Over-Expressed In Murine Hematopoietic Progenitors.

Purinergic Stimulation of Human Bone Marrow-Derived Mesenchymal Stem Cells Modulate Their Function and Differentiation Potential.

The CD47 Pathway Is Deregulated In Human Immune Thrombocytopenia (ITP).

CD133 + Pluripotent Stem Cells for the Treatment of Chronic Liver Failure.

Human Monocyte-Derived Dendritic Cells Are Tolerogenic through Both IDO1 and IDO2

Decreased Expression of Indoleamine 2,3-Dioxygenase 1 (IDO 1) in Dendritic Cells From Patients with Immune Thrombocytopenia (ITP) Correlates with Impaired Regulatory T Cells Development

Purinergic Signaling Differentially Modulates Normal and Leukemic Hematopoiesis.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only